— Know what they know.
Not Investment Advice
Also trades as: LOVE.TO (TSX) · $vol 0M · LOVE.V (TSXV) · $vol 0M

LOVFF OTC

Cannara Biotech Inc.
1W: -2.0% 1M: +2.1% 3M: +25.4% YTD: +13.8% 1Y: +15.6% 3Y: +113.1% 5Y: +2.8%
$1.48
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 66 · $146.2M mcap · 47M float · 0.031% daily turnover · Short 49% of daily vol

Balance Sheet Trends

Total Assets
$169M +9.0% ▲
5Y CAGR: +25.2%
Total Liabilities
$66M -0.5% ▼
5Y CAGR: +32.1%
Shareholders Equity
$102M +16.2% ▲
5Y CAGR: +21.7%
Cash & Investments
$14M +116.9% ▲
5Y CAGR: +13.1%
Total Debt
$42M -14.0% ▼
5Y CAGR: +26.3%
Net Debt
$27M -34.7% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$8M$12M$4M$7M$14M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$8M$12M$4M$7M$14M
Net Receivables$3M$9M$11M$13M$14M
Inventory$7M$19M$34M$40M$45M
Other Current Assets$0$0$3M$8M$7M
Total Current Assets$19M$41M$52M$67M$82M
Property, Plant & Equip.$72M$84M$89M$85M$86M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$73K$0$0$0$0
Other Non-Current Assets$396K$296K$390K$256K$488K
Total Non-Current Assets$73M$85M$90M$87M$86M
Total Assets$92M$126M$142M$155M$169M
— Liabilities —
Accounts Payable$6M$9M$9M$10M$11M
Short-Term Debt$303K$2M$6M$9M$13M
Deferred Revenue$42K$45K$161K$135K$133K
Other Current Liabilities$72K$774K$1M$0$0
Total Current Liabilities$7M$12M$21M$27M$34M
Long-Term Debt$20M$46M$40M$38M$28M
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$21M$47M$41M$40M$32M
Total Liabilities$28M$59M$62M$67M$66M
— Equity —
Common Stock$83M$83M$89M$89M$90M
Retained Earnings-$29M-$26M-$19M-$13M$178K
Accumulated OCI$100K$15K-$69K$0$0
Total Stockholders Equity$64M$67M$80M$88M$102M
Total Liabilities & Equity$92M$126M$142M$155M$169M
— Key Metrics —
Total Debt$21M$48M$46M$48M$42M
Net Debt$13M$36M$42M$42M$27M
Total Investments$73K$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms